» Articles » PMID: 20385094

ERK2 but Not ERK1 Induces Epithelial-to-mesenchymal Transformation Via DEF Motif-dependent Signaling Events

Overview
Journal Mol Cell
Publisher Cell Press
Specialty Cell Biology
Date 2010 Apr 14
PMID 20385094
Citations 174
Authors
Affiliations
Soon will be listed here.
Abstract

Hyperactivation of Ras-ERK1/2 signaling is critical to the development of many human malignancies, but little is known regarding the specific contribution of ERK1 or ERK2 to oncogenic processes. We demonstrate that ERK2 but not ERK1 signaling is necessary for Ras-induced epithelial-to-mesenchymal transformation (EMT). Further, ERK2 but not ERK1 overexpression is sufficient to induce EMT. Many ERK1/2-interacting proteins contain amino acid motifs, e.g., DEF or D-motifs, which regulate docking with ERK1/2. Remarkably, ERK2 signaling to DEF motif-containing targets is required to induce EMT and correlates with increased migration, invasion, and survival. Importantly, the late-response gene product Fra1 is necessary for Ras- and ERK2-induced EMT through upregulation of ZEB1/2 proteins. Thus, an apparent critical role for ERK2 DEF motif signaling during tumorigenesis is the regulation of Fra1 and the subsequent induction of ZEB1/2, suggesting a potential therapeutic target for Ras-regulated tumorigenesis.

Citing Articles

Loss of E-cadherin Activates EGFR-MEK/ERK Signaling, Promoting Cervical Cancer Progression.

Yun H, Han G, Wee D, Chay D, Chung J, Kim J Cancer Genomics Proteomics. 2025; 22(2):271-284.

PMID: 39993806 PMC: 11880930. DOI: 10.21873/cgp.20501.


Cooperation between the Hippo and MAPK pathway activation drives acquired resistance to TEAD inhibition.

Paul S, Hagenbeek T, Tremblay J, Kameswaran V, Ong C, Liu C Nat Commun. 2025; 16(1):1743.

PMID: 39966375 PMC: 11836325. DOI: 10.1038/s41467-025-56634-y.


Overexpression of Nogo-A changes nerve growth factor signaling dynamics in PC12 cells.

Farrer R, Kartje G Cell Signal. 2024; 127:111569.

PMID: 39675688 PMC: 11807749. DOI: 10.1016/j.cellsig.2024.111569.


MicroRNA-145-5p inhibits the tumorigenesis of breast cancer through SENP2-regulated ubiquitination of ERK2.

Chen X, Li D, Su Q, Ling X, Ding S, Xu R Cell Mol Life Sci. 2024; 81(1):461.

PMID: 39578257 PMC: 11584840. DOI: 10.1007/s00018-024-05505-8.


Methods and computational tools to study eukaryotic cell migration .

Toscano E, Cimmino E, Pennacchio F, Riccio P, Poli A, Liu Y Front Cell Dev Biol. 2024; 12:1385991.

PMID: 38887515 PMC: 11180820. DOI: 10.3389/fcell.2024.1385991.


References
1.
Casalino L, De Cesare D, Verde P . Accumulation of Fra-1 in ras-transformed cells depends on both transcriptional autoregulation and MEK-dependent posttranslational stabilization. Mol Cell Biol. 2003; 23(12):4401-15. PMC: 156136. DOI: 10.1128/MCB.23.12.4401-4415.2003. View

2.
Hoshino R, Chatani Y, Yamori T, Tsuruo T, Oka H, Yoshida O . Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors. Oncogene. 1999; 18(3):813-22. DOI: 10.1038/sj.onc.1202367. View

3.
Li J, Johnson S . ERK2 is required for efficient terminal differentiation of skeletal myoblasts. Biochem Biophys Res Commun. 2006; 345(4):1425-33. DOI: 10.1016/j.bbrc.2006.05.051. View

4.
Thiery J . Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol. 2003; 15(6):740-6. DOI: 10.1016/j.ceb.2003.10.006. View

5.
LeFloch R, Pouyssegur J, Lenormand P . Single and combined silencing of ERK1 and ERK2 reveals their positive contribution to growth signaling depending on their expression levels. Mol Cell Biol. 2007; 28(1):511-27. PMC: 2223286. DOI: 10.1128/MCB.00800-07. View